Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Nexalin Technology, Inc. (NXL) just unveiled an update.
Michael Nketiah will step down as Nexalin Technology Inc.’s Senior Vice President of Clinical, Quality, & Regulatory Affairs on August 16, 2024, to pursue a new professional opportunity. His departure is amicable, with no disagreements with the company reported. Nketiah will continue his duties until the effective date of his resignation.
For an in-depth examination of NXL stock, go to TipRanks’ Stock Analysis page.
